Buscar resultados de ensayos clínicos
Human T-cell Leukemia Virus Type 1 - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Evaluation of Patients With HAM/TSP Condición:
Fecha: 1999-11-03 |
Completed |
Nombre del estudio: Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Condición: HTLV I Associated Myelopathy Fecha: 2008-10-15 Intervenciones: Drug: ciclosporin Ciclosporin 2.5 - 5mg/kg/day in two equally divided doses. dose adjusted according to |
Completed |
Nombre del estudio: A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis Condición: HTLV-I Fecha: 2006-06-19 |
Completed |
Nombre del estudio: Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) Condición: HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL) Fecha: 2011-08-16 Intervenciones: Drug: CHOP-daclizumab Other Name: CHOP-Zenapax |
Completed |
Nombre del estudio: Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases Condición:
|
Terminated |
Nombre del estudio: The HAM Infliximab Study Condición: HTLV-I-associated Myelopathy Fecha: 2009-01-14 Intervenciones: Drug: Infliximab Infliximab 3mg/kg infused intravenously at weeks 0, 2 and 8 and then every 8 weeks unti |
Recruiting |
Nombre del estudio: Sensorimotor Exercises in Virtual Reality Platform in Individuals With Human T-lymphotropic Virus Condición: HTLV-1 Fecha: 2016-08-11 Intervenciones: Other: Video game The protocol sensorimotor exercises consist of a virtual game that attaches to the Nin |
Enrolling by invitation |
Nombre del estudio: Evaluation of InnoLIA HTLV I/II Score Condición: Human T-Lymphotrophic Virus Type I and/or Type II Fecha: 2010-06-22 Intervenciones: Device: InnoLIA HTLV I/II Score line immunoassay This intervention consists of testing a residual serum |
Terminated |
Nombre del estudio: Safety and Efficiency Study of Valproic Acid In HAM/TSP Condición: HTLV-I-Associated Myelopathy Fecha: 2007-08-20 Intervenciones: Drug: Valproic Acid Valproic acid by oral route (20mg/Kg/day) during one year. |
Completed |
Nombre del estudio: Anti-Tac for Treatment of Leukemia Condición:
Fecha: 2000-01-18 Intervenciones: Biological: daclizumab Other Name: Zenapax |